Wisconsin SB 1149: Relating to: prescription drug cost reporting by manufacturers, making an appropriation, and providing a penalty. (FE)

Status: Failed to pass pursuant to Senate Joint Resolution 1 (as of 2026-03-23)

State: Wisconsin · Session: 2025 · Bill: SB 1149

Sponsors: Carpenter, Dassler-Alfheim, Hesselbein, Larson, Pfaff, Ratcliff, Roys, Smith, Spreitzer

View Wisconsin SB 1149 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.